The biotech, which has raised more than $140 million over several investment rounds in the last few years from the likes of ...

Norgen’s microScript microRNA cDNA Synthesis Kit is a complete, ready-to-use kit for reverse transcription of microRNA from either whole RNA or enriched microRNA preparations. The kit includes ...

Victor Ambros and Gary Ruvkun won this year’s Physiology or Medicine award for the discovery of microRNA and its role in post-transcriptional gene regulation. Danielle is a Senior Editor at The ...

“The microRNA fraction is less complex,” he says, “but that doesn't mean you can get away with a poor experimental design or fewer replicates.” The obvious solution is to verify results ...

The following is a summary of “Identification of hypertension subtypes using microRNA profiles and machine learning,” ...

A DNA nanomachine selectively targets skin cancer by detecting microRNA-7, activating phototherapy and releasing chemotherapy ...

TransCode Therapeutics (RNAZ) announced that the first patient in Cohort 4 of its Phase I clinical trial has received their initial dose.

Laura is an Assistant Editor for The Scientist. She has a background in microbiology. Her science communication work spans journalism and public engagement. View Full Profile. Learn about our ...

TransCode begins patient dosing in Cohort 4 of phase 1 trial with TTX-MC138 to treat metastatic cancer: Boston Monday, March 31, 2025, 18:00 Hrs [IST] TransCode Therapeutics, Inc.

Scientists have developed a new transgene control system that shows early promise for treating rare brain disorder Rett syndrome.